Raju Mantena
Chairman and CEO
Raju founded Ingenus Pharmaceuticals in 2010 to help build the bridge between quality products and affordability.
He is a career innovator responsible for providing overall leadership and strategic direction of the business.
Raju has founded multiple successful healthcare ventures prior to Ingenus, bringing over 25 years of expertise to our leadership team.
Prior to creating Ingenus Pharmaceuticals, he founded ICORE Healthcare, a company that provides health plans with solutions to manage specialty cost trends. Prior to ICORE, he founded International Oncology Network (ION), an oncology group purchasing organization, and OncoScripts, one of the first oncology focused specialty pharmacies.
Raju holds a degree in clinical pharmacy from the University of Maryland and a bachelor’s degree in computer science and engineering from JNTU (Jawaharlal Nehru Technological University) in India.
Andrew Gellman
President
As President of Ingenus Pharmaceuticals, Andrew provides leadership and tactical direction. Prior to creating Ingenus, Andrew served as the chief operating officer of ICORE Healthcare; a specialty drug management company focused on managing specialty drug spend. He has also served as the president/GM of Integrated Commercialization Solutions (ICS), a third party logistics provider to the pharmaceutical industry.
Paul Dutra
Executive Vice President
Paul brings extensive experience in the pharmaceutical industry, the majority of which he spent starting and building-out generic companies. Previously, Paul was the Executive Vice President of North American Generics for Glenmark Pharmaceuticals. During his tenure, he was instrumental in the formation and tremendous growth of the company. He was responsible for sales and marketing, contracting, customer service, supply chain, and warehouse distribution.
Mukti Gande
Chief Scientific Officer
Mukti has over two decades of successful experience in pharmaceutical formulation R&D, API sourcing,
bio-studies/clinical studies and regulatory submissions. He has successfully identified, developed and commercialized over 100 generic products for the U.S. market. A serial entrepreneur, Mukti has co-founded five successful pharmaceutical business ventures.
These include CorePharm; a generic pharmaceutical company, Synerx Pharma; a specialty injectable company; Apicore; a specialty API development and manufacturing company, RiconPharma; a specialty pharmaceutical company, and Mirror Pharmaceuticals; a pharmaceutical development and manufacturing company.
Brahmaji Valiveti
Chief Strategic Officer
Brahmaji comes to Ingenus with a diverse and strong background in pharmaceutical manufacturing and retail pharmacies. Brahmaji is a successful businessperson with an interest in the entire pharmaceutical landscape covering API, product development, manufacturing, distribution, GPO, and retail.
Before coming to the U.S., he held a position as a principal at the PES College of Pharmacy, India. He was instrumental in starting the college and making it into one of the country’s best and most-trusted colleges at the young age of 24 years old. He also worked at Lederle Labs, the generic division of Wyeth Pharmaceuticals, for over two years in the manufacturing, analytical method development, quality control and release.
Dr. Samir Mehta
Chief Operating Officer
As COO of Ingenus, Samir is responsible for strategic and operational leadership for the growth of the company. Prior to Ingenus, Dr. Mehta was the President of Accord Healthcare, USA where he was responsible for the company’s inception, growth and management. Samir brings decades of pharmaceutical experience in overseeing areas such as Hatch Waxman litigation, generic sales and marketing, and pharmaceutical product development and registration.
Dr. Mehta earned his PhD in Pharmaceutical Sciences from the University of Georgia.
Raj Devalapalli
President, Manufacturing Services
Raj has over two decades of experience in pharmaceutical product and process development, product enhancement, lifecycle management, scale-up, technology transfer, validation, manufacturing, quality management and regulatory compliance. He has held key positions in companies such as Pfizer, Warner-Lambert, Becton Dickinson Transdermal Research, and Penwest Pharmaceuticals.
Raj holds an MS degree in Industrial Pharmacy/Pharmaceutics and an MBA in Pharmaceutical Business. He is also a registered pharmacist in the state of New Jersey.
Matthew Baumgartner
Chief Financial Officer and Authorized House General Counsel (licensed in Ohio only)
As the CFO for Ingenus Pharmaceuticals, Matthew is responsible for the financial regulations of the company. Matthew has an extensive background in organizational and operational management, financial structures and M&A. He began his professional career in public accounting with Peat Marwick (later KPMG). Throughout his career, Matthew has worked in multiple industries including healthcare, finance, and manufacturing.
Matthew holds both a BBA in accounting and a JD from Cleveland State University. Additionally, he has been admitted to the Ohio Bar and holds CPA and CGMA certifications.
Jeanmarie Dunk
Vice President
Jeanmarie joined Ingenus in 2012 and initially was responsible for the overall operations of the business, which included customer service, warehousing and distribution, information technology, supply chain management, account management, pharmacovigilance, contracts and chargeback administration, government pricing and Medicaid administration.
In 2022, Jeanmarie moved into an Executive Coaching position and began Ingenus’ Executive Leadership Training Program. As a seasoned leader she has been instrumental in sharing her management expertise to enhance the Ingenus management team. Ingenus believes its future success is dependent on optimizing its human capital and is fully committed to investing in its employees. These leadership training programs are focused on management skills, team building, communication, employee engagement and autonomy, individual growth, and development.
Jeanmarie has over 30 years of experience in the pharmaceutical industry, starting her career at Barre-National (Alpharma). She later worked for Geneva Pharmaceuticals, ENDO Pharmaceuticals, Dr. Reddy’s Laboratories, and Wockhardt USA.
Dr. Praveen Billa
Senior Vice President of Scientific Affairs
Praveen has over 20 years of experience in pre-formulations, analytical R&D, formulation development, bio-studies, and regulatory submissions. He held key positions in pharmaceutical R&D at Wockhardt, Reddy’s Laboratories and Orchid Pharma, Ltd. Dr. Billa was instrumental in developing over 100 ANDAs and managed over 20 Paragraph IV challenges.
He has developed several complex dosage forms, modified release tablets and capsules, suspensions and lyophilized injectables, and has developed over 30 Injectable ANDA products, which involved PENAMS and Cephalosporins. Dr. Billa has significant experience in solid oral dosages (IR and MR), topicals, liquids, and parenterals, and holds several patents (U.S. and WO) and publications.
